Literature DB >> 120117

Histological and ultrastructural studies of the cornea in Maroteaux-Lamy syndrome.

I Süveges.   

Abstract

The author presents the histologic and electron-microscopic examination of the cornea of a patient with Maroteaux-Lamy syndrome. Histochemic examinations established the absence of keratin sulfate and heparin sulfate in the accumulated material. By means of electron microscopy three cell types have been found in the stroma which may show, besides the storage of the accumulated glycosaminoglycans, the morphologic signs of the pathologic enzyme-substrate connection. Considering the presence of the lipidlike material, the question arises whether the Maroteaux-Lamy syndrome belongs to mucolipidoses.

Entities:  

Mesh:

Year:  1979        PMID: 120117     DOI: 10.1007/bf00413322

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  8 in total

1.  Ultrastructural and histochemical studies of a newly recognized form of systemic mucopolysaccharidosis. (Maroteaux-Lamy syndrome, mild phenotype).

Authors:  H A Quigley; K R Kenyon
Journal:  Am J Ophthalmol       Date:  1974-06       Impact factor: 5.258

2.  The systemic mucopolysaccharidoses. Ultrastructural and histochemical studies of conjunctiva and skin.

Authors:  K R Kenyon; H A Quigley; I E Hussels; R G Wyllie; M F Goldberg
Journal:  Am J Ophthalmol       Date:  1972-06       Impact factor: 5.258

3.  Studies on corneal polysaccharides. 8. Changes in the glycosaminoglycans in some human corneal disorders.

Authors:  A Anseth
Journal:  Exp Eye Res       Date:  1969-10       Impact factor: 3.467

4.  Reduced arylsulfatase B activity of the mutant enzyme protein in Maroteaux-Lamy syndrome.

Authors:  E Shapira; R R DeGregorio; R Matalon; H L Nadler
Journal:  Biochem Biophys Res Commun       Date:  1975-01-20       Impact factor: 3.575

5.  Ocular pathology of the Maroteaux-Lamy syndrome (systemic mucopolysaccharidosis type VI). Histologic and ultrastructural report of two cases.

Authors:  K R Kenyon; T M Topping; W R Green; A E Maumenee
Journal:  Am J Ophthalmol       Date:  1972-05       Impact factor: 5.258

6.  Arylsulfatase B deficiency in Maroteaux-Lamy syndrome cultured fibroblasts.

Authors:  A L Fluharty; R L Stevens; D L Sanders; H Kihara
Journal:  Biochem Biophys Res Commun       Date:  1974-07-24       Impact factor: 3.575

7.  [Pathobiochemical aspects of lysosomal enzymes with special reference to lysosomal storage diseases (author's transl)].

Authors:  H Kresse
Journal:  Wien Klin Wochenschr       Date:  1978-05-12       Impact factor: 1.704

8.  Maroteaux-Lamy disease (mucopolysaccharidosis VI), subtype A: deficiency of a N-acetylgalactosamine-4-sulfatase.

Authors:  J F O'Brien; M Cantz; J Spranger
Journal:  Biochem Biophys Res Commun       Date:  1974-10-08       Impact factor: 3.575

  8 in total
  1 in total

1.  Does enzyme replacement therapy influence the ocular changes in type VI mucopolysaccharidosis?

Authors:  Susanne Pitz; Olufunmilola Ogun; Laila Arash; Elke Miebach; Michael Beck
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-22       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.